Laboratory-confirmed influenza B infection in immunized long-term care facility residents receiving oseltamivir prophylaxis in Ontario.
Identifieur interne : 000347 ( Main/Exploration ); précédent : 000346; suivant : 000348Laboratory-confirmed influenza B infection in immunized long-term care facility residents receiving oseltamivir prophylaxis in Ontario.
Auteurs : Anne-Luise Winter [Canada] ; Adriana Peci ; Alireza Eshaghi ; Michelle Baird ; Nader Memari ; Erik Kristjanson ; Elizabeth Balogun ; Rachel R. Higgins ; Aimin Li ; David J. Farrell ; Jonathan B. GubbaySource :
- Infection control and hospital epidemiology [ 1559-6834 ] ; 2013.
Descripteurs français
- KwdFr :
- Adulte d'âge moyen, Antiviraux (usage thérapeutique), Concentration inhibitrice 50, Flambées de maladies, Grippe humaine (), Grippe humaine (traitement médicamenteux), Grippe humaine (virologie), Grippe humaine (épidémiologie), Humains, Ontario (épidémiologie), Oséltamivir (usage thérapeutique), Phylogénie, Prophylaxie après exposition, Soins de longue durée, Tests de sensibilité microbienne, Vaccins antigrippaux, Virus influenza B (), Virus influenza B (génétique), Virus influenza B (isolement et purification).
- MESH :
- génétique : Virus influenza B.
- isolement et purification : Virus influenza B.
- traitement médicamenteux : Grippe humaine.
- usage thérapeutique : Antiviraux, Oséltamivir.
- virologie : Grippe humaine.
- épidémiologie : Grippe humaine, Ontario.
- Adulte d'âge moyen, Concentration inhibitrice 50, Flambées de maladies, Grippe humaine, Humains, Phylogénie, Prophylaxie après exposition, Soins de longue durée, Tests de sensibilité microbienne, Vaccins antigrippaux, Virus influenza B.
English descriptors
- KwdEn :
- Antiviral Agents (therapeutic use), Disease Outbreaks, Humans, Influenza B virus (drug effects), Influenza B virus (genetics), Influenza B virus (isolation & purification), Influenza Vaccines, Influenza, Human (drug therapy), Influenza, Human (epidemiology), Influenza, Human (prevention & control), Influenza, Human (virology), Inhibitory Concentration 50, Long-Term Care, Microbial Sensitivity Tests, Middle Aged, Ontario (epidemiology), Oseltamivir (therapeutic use), Phylogeny, Post-Exposure Prophylaxis.
- MESH :
- chemical , therapeutic use : Antiviral Agents, Oseltamivir.
- geographic , epidemiology : Ontario.
- drug effects : Influenza B virus.
- drug therapy : Influenza, Human.
- epidemiology : Influenza, Human.
- genetics : Influenza B virus.
- isolation & purification : Influenza B virus.
- prevention & control : Influenza, Human.
- virology : Influenza, Human.
- Disease Outbreaks, Humans, Influenza Vaccines, Inhibitory Concentration 50, Long-Term Care, Microbial Sensitivity Tests, Middle Aged, Phylogeny, Post-Exposure Prophylaxis.
Abstract
We report on an influenza B outbreak in an Ontario long-term care facility in which 2 immunized residents receiving oseltamivir prophylaxis for at least 5 days developed laboratory-confirmed influenza B infection. All isolates were tested for the most common oseltamivir resistance, and none of them had resistance identified.
DOI: 10.1086/673455
PubMed: 24113612
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Laboratory-confirmed influenza B infection in immunized long-term care facility residents receiving oseltamivir prophylaxis in Ontario.</title><author><name sortKey="Winter, Anne Luise" sort="Winter, Anne Luise" uniqKey="Winter A" first="Anne-Luise" last="Winter">Anne-Luise Winter</name><affiliation wicri:level="1"><nlm:affiliation>Ontario Agency for Health Protection and Promotion, Toronto, Ontario, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Ontario Agency for Health Protection and Promotion, Toronto, Ontario</wicri:regionArea><wicri:noRegion>Ontario</wicri:noRegion></affiliation></author><author><name sortKey="Peci, Adriana" sort="Peci, Adriana" uniqKey="Peci A" first="Adriana" last="Peci">Adriana Peci</name></author><author><name sortKey="Eshaghi, Alireza" sort="Eshaghi, Alireza" uniqKey="Eshaghi A" first="Alireza" last="Eshaghi">Alireza Eshaghi</name></author><author><name sortKey="Baird, Michelle" sort="Baird, Michelle" uniqKey="Baird M" first="Michelle" last="Baird">Michelle Baird</name></author><author><name sortKey="Memari, Nader" sort="Memari, Nader" uniqKey="Memari N" first="Nader" last="Memari">Nader Memari</name></author><author><name sortKey="Kristjanson, Erik" sort="Kristjanson, Erik" uniqKey="Kristjanson E" first="Erik" last="Kristjanson">Erik Kristjanson</name></author><author><name sortKey="Balogun, Elizabeth" sort="Balogun, Elizabeth" uniqKey="Balogun E" first="Elizabeth" last="Balogun">Elizabeth Balogun</name></author><author><name sortKey="Higgins, Rachel R" sort="Higgins, Rachel R" uniqKey="Higgins R" first="Rachel R" last="Higgins">Rachel R. Higgins</name></author><author><name sortKey="Li, Aimin" sort="Li, Aimin" uniqKey="Li A" first="Aimin" last="Li">Aimin Li</name></author><author><name sortKey="Farrell, David J" sort="Farrell, David J" uniqKey="Farrell D" first="David J" last="Farrell">David J. Farrell</name></author><author><name sortKey="Gubbay, Jonathan B" sort="Gubbay, Jonathan B" uniqKey="Gubbay J" first="Jonathan B" last="Gubbay">Jonathan B. Gubbay</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2013">2013</date><idno type="RBID">pubmed:24113612</idno><idno type="pmid">24113612</idno><idno type="doi">10.1086/673455</idno><idno type="wicri:Area/Main/Corpus">000324</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000324</idno><idno type="wicri:Area/Main/Curation">000324</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000324</idno><idno type="wicri:Area/Main/Exploration">000324</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Laboratory-confirmed influenza B infection in immunized long-term care facility residents receiving oseltamivir prophylaxis in Ontario.</title><author><name sortKey="Winter, Anne Luise" sort="Winter, Anne Luise" uniqKey="Winter A" first="Anne-Luise" last="Winter">Anne-Luise Winter</name><affiliation wicri:level="1"><nlm:affiliation>Ontario Agency for Health Protection and Promotion, Toronto, Ontario, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Ontario Agency for Health Protection and Promotion, Toronto, Ontario</wicri:regionArea><wicri:noRegion>Ontario</wicri:noRegion></affiliation></author><author><name sortKey="Peci, Adriana" sort="Peci, Adriana" uniqKey="Peci A" first="Adriana" last="Peci">Adriana Peci</name></author><author><name sortKey="Eshaghi, Alireza" sort="Eshaghi, Alireza" uniqKey="Eshaghi A" first="Alireza" last="Eshaghi">Alireza Eshaghi</name></author><author><name sortKey="Baird, Michelle" sort="Baird, Michelle" uniqKey="Baird M" first="Michelle" last="Baird">Michelle Baird</name></author><author><name sortKey="Memari, Nader" sort="Memari, Nader" uniqKey="Memari N" first="Nader" last="Memari">Nader Memari</name></author><author><name sortKey="Kristjanson, Erik" sort="Kristjanson, Erik" uniqKey="Kristjanson E" first="Erik" last="Kristjanson">Erik Kristjanson</name></author><author><name sortKey="Balogun, Elizabeth" sort="Balogun, Elizabeth" uniqKey="Balogun E" first="Elizabeth" last="Balogun">Elizabeth Balogun</name></author><author><name sortKey="Higgins, Rachel R" sort="Higgins, Rachel R" uniqKey="Higgins R" first="Rachel R" last="Higgins">Rachel R. Higgins</name></author><author><name sortKey="Li, Aimin" sort="Li, Aimin" uniqKey="Li A" first="Aimin" last="Li">Aimin Li</name></author><author><name sortKey="Farrell, David J" sort="Farrell, David J" uniqKey="Farrell D" first="David J" last="Farrell">David J. Farrell</name></author><author><name sortKey="Gubbay, Jonathan B" sort="Gubbay, Jonathan B" uniqKey="Gubbay J" first="Jonathan B" last="Gubbay">Jonathan B. Gubbay</name></author></analytic><series><title level="j">Infection control and hospital epidemiology</title><idno type="eISSN">1559-6834</idno><imprint><date when="2013" type="published">2013</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antiviral Agents (therapeutic use)</term><term>Disease Outbreaks</term><term>Humans</term><term>Influenza B virus (drug effects)</term><term>Influenza B virus (genetics)</term><term>Influenza B virus (isolation & purification)</term><term>Influenza Vaccines</term><term>Influenza, Human (drug therapy)</term><term>Influenza, Human (epidemiology)</term><term>Influenza, Human (prevention & control)</term><term>Influenza, Human (virology)</term><term>Inhibitory Concentration 50</term><term>Long-Term Care</term><term>Microbial Sensitivity Tests</term><term>Middle Aged</term><term>Ontario (epidemiology)</term><term>Oseltamivir (therapeutic use)</term><term>Phylogeny</term><term>Post-Exposure Prophylaxis</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte d'âge moyen</term><term>Antiviraux (usage thérapeutique)</term><term>Concentration inhibitrice 50</term><term>Flambées de maladies</term><term>Grippe humaine ()</term><term>Grippe humaine (traitement médicamenteux)</term><term>Grippe humaine (virologie)</term><term>Grippe humaine (épidémiologie)</term><term>Humains</term><term>Ontario (épidémiologie)</term><term>Oséltamivir (usage thérapeutique)</term><term>Phylogénie</term><term>Prophylaxie après exposition</term><term>Soins de longue durée</term><term>Tests de sensibilité microbienne</term><term>Vaccins antigrippaux</term><term>Virus influenza B ()</term><term>Virus influenza B (génétique)</term><term>Virus influenza B (isolement et purification)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antiviral Agents</term><term>Oseltamivir</term></keywords><keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>Ontario</term></keywords><keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Influenza B virus</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Influenza, Human</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Influenza, Human</term></keywords><keywords scheme="MESH" qualifier="genetics" xml:lang="en"><term>Influenza B virus</term></keywords><keywords scheme="MESH" qualifier="génétique" xml:lang="fr"><term>Virus influenza B</term></keywords><keywords scheme="MESH" qualifier="isolation & purification" xml:lang="en"><term>Influenza B virus</term></keywords><keywords scheme="MESH" qualifier="isolement et purification" xml:lang="fr"><term>Virus influenza B</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Influenza, Human</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Grippe humaine</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Antiviraux</term><term>Oséltamivir</term></keywords><keywords scheme="MESH" qualifier="virologie" xml:lang="fr"><term>Grippe humaine</term></keywords><keywords scheme="MESH" qualifier="virology" xml:lang="en"><term>Influenza, Human</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Grippe humaine</term><term>Ontario</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Disease Outbreaks</term><term>Humans</term><term>Influenza Vaccines</term><term>Inhibitory Concentration 50</term><term>Long-Term Care</term><term>Microbial Sensitivity Tests</term><term>Middle Aged</term><term>Phylogeny</term><term>Post-Exposure Prophylaxis</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte d'âge moyen</term><term>Concentration inhibitrice 50</term><term>Flambées de maladies</term><term>Grippe humaine</term><term>Humains</term><term>Phylogénie</term><term>Prophylaxie après exposition</term><term>Soins de longue durée</term><term>Tests de sensibilité microbienne</term><term>Vaccins antigrippaux</term><term>Virus influenza B</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">We report on an influenza B outbreak in an Ontario long-term care facility in which 2 immunized residents receiving oseltamivir prophylaxis for at least 5 days developed laboratory-confirmed influenza B infection. All isolates were tested for the most common oseltamivir resistance, and none of them had resistance identified. </div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">24113612</PMID><DateCompleted><Year>2014</Year><Month>06</Month><Day>26</Day></DateCompleted><DateRevised><Year>2015</Year><Month>01</Month><Day>27</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1559-6834</ISSN><JournalIssue CitedMedium="Internet"><Volume>34</Volume><Issue>11</Issue><PubDate><Year>2013</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Infection control and hospital epidemiology</Title><ISOAbbreviation>Infect Control Hosp Epidemiol</ISOAbbreviation></Journal><ArticleTitle>Laboratory-confirmed influenza B infection in immunized long-term care facility residents receiving oseltamivir prophylaxis in Ontario.</ArticleTitle><Pagination><MedlinePgn>1225-8</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1086/673455</ELocationID><Abstract><AbstractText>We report on an influenza B outbreak in an Ontario long-term care facility in which 2 immunized residents receiving oseltamivir prophylaxis for at least 5 days developed laboratory-confirmed influenza B infection. All isolates were tested for the most common oseltamivir resistance, and none of them had resistance identified. </AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Winter</LastName><ForeName>Anne-Luise</ForeName><Initials>AL</Initials><AffiliationInfo><Affiliation>Ontario Agency for Health Protection and Promotion, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peci</LastName><ForeName>Adriana</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Eshaghi</LastName><ForeName>Alireza</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Baird</LastName><ForeName>Michelle</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Memari</LastName><ForeName>Nader</ForeName><Initials>N</Initials></Author><Author ValidYN="Y"><LastName>Kristjanson</LastName><ForeName>Erik</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>Balogun</LastName><ForeName>Elizabeth</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>Higgins</LastName><ForeName>Rachel R</ForeName><Initials>RR</Initials></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Aimin</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Farrell</LastName><ForeName>David J</ForeName><Initials>DJ</Initials></Author><Author ValidYN="Y"><LastName>Gubbay</LastName><ForeName>Jonathan B</ForeName><Initials>JB</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2013</Year><Month>09</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Infect Control Hosp Epidemiol</MedlineTA><NlmUniqueID>8804099</NlmUniqueID><ISSNLinking>0899-823X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007252">Influenza Vaccines</NameOfSubstance></Chemical><Chemical><RegistryNumber>20O93L6F9H</RegistryNumber><NameOfSubstance UI="D053139">Oseltamivir</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CitationSubset>N</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004196" MajorTopicYN="Y">Disease Outbreaks</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009981" MajorTopicYN="N">Influenza B virus</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000302" MajorTopicYN="Y">isolation & purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007252" MajorTopicYN="N">Influenza Vaccines</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName><QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020128" MajorTopicYN="N">Inhibitory Concentration 50</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008134" MajorTopicYN="N">Long-Term Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008826" MajorTopicYN="N">Microbial Sensitivity Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009864" MajorTopicYN="N" Type="Geographic">Ontario</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D053139" MajorTopicYN="N">Oseltamivir</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010802" MajorTopicYN="N">Phylogeny</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D056990" MajorTopicYN="N">Post-Exposure Prophylaxis</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2013</Year><Month>10</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2013</Year><Month>10</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>6</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24113612</ArticleId><ArticleId IdType="doi">10.1086/673455</ArticleId><ArticleId IdType="pii">S0195941700034305</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>Canada</li></country></list><tree><noCountry><name sortKey="Baird, Michelle" sort="Baird, Michelle" uniqKey="Baird M" first="Michelle" last="Baird">Michelle Baird</name><name sortKey="Balogun, Elizabeth" sort="Balogun, Elizabeth" uniqKey="Balogun E" first="Elizabeth" last="Balogun">Elizabeth Balogun</name><name sortKey="Eshaghi, Alireza" sort="Eshaghi, Alireza" uniqKey="Eshaghi A" first="Alireza" last="Eshaghi">Alireza Eshaghi</name><name sortKey="Farrell, David J" sort="Farrell, David J" uniqKey="Farrell D" first="David J" last="Farrell">David J. Farrell</name><name sortKey="Gubbay, Jonathan B" sort="Gubbay, Jonathan B" uniqKey="Gubbay J" first="Jonathan B" last="Gubbay">Jonathan B. Gubbay</name><name sortKey="Higgins, Rachel R" sort="Higgins, Rachel R" uniqKey="Higgins R" first="Rachel R" last="Higgins">Rachel R. Higgins</name><name sortKey="Kristjanson, Erik" sort="Kristjanson, Erik" uniqKey="Kristjanson E" first="Erik" last="Kristjanson">Erik Kristjanson</name><name sortKey="Li, Aimin" sort="Li, Aimin" uniqKey="Li A" first="Aimin" last="Li">Aimin Li</name><name sortKey="Memari, Nader" sort="Memari, Nader" uniqKey="Memari N" first="Nader" last="Memari">Nader Memari</name><name sortKey="Peci, Adriana" sort="Peci, Adriana" uniqKey="Peci A" first="Adriana" last="Peci">Adriana Peci</name></noCountry><country name="Canada"><noRegion><name sortKey="Winter, Anne Luise" sort="Winter, Anne Luise" uniqKey="Winter A" first="Anne-Luise" last="Winter">Anne-Luise Winter</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/GrippeCanadaV3/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000347 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000347 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= GrippeCanadaV3
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:24113612
|texte= Laboratory-confirmed influenza B infection in immunized long-term care facility residents receiving oseltamivir prophylaxis in Ontario.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:24113612" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a GrippeCanadaV3
| This area was generated with Dilib version V0.6.35. |  |